Ylva Ginsberg

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    BMC Psychiatry 10:112. 2010
  2. ncbi Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry and Center of Neurodevelopmental Disorders, Karolinska Institutet, Stockholm, Sweden
    Br J Psychiatry 200:68-73. 2012
  3. ncbi Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Eur Arch Psychiatry Clin Neurosci 262:705-24. 2012

Detail Information

Publications3

  1. ncbi Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    BMC Psychiatry 10:112. 2010
    ..We estimated the prevalence of ADHD among longer-term prison inmates, described symptoms and cognitive functioning, and compared findings with ADHD among psychiatric outpatients and healthy controls...
  2. ncbi Methylphenidate treatment of adult male prison inmates with attention-deficit hyperactivity disorder: randomised double-blind placebo-controlled trial with open-label extension
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry and Center of Neurodevelopmental Disorders, Karolinska Institutet, Stockholm, Sweden
    Br J Psychiatry 200:68-73. 2012
    ..Attention-deficit hyperactivity disorder (ADHD) is highly prevalent in prison inmates, but pharmacological treatment has not yet been evaluated in this group...
  3. ncbi Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate
    Ylva Ginsberg
    Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet, Stockholm, Sweden
    Eur Arch Psychiatry Clin Neurosci 262:705-24. 2012
    ..Finally, investigators' and self-ratings of ADHD symptoms associated significantly at baseline with increasing convergence over time...